Uzi Sofer - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Role
Chief Executive Officer, Director
Signature
/s/ Uzi Sofer
Issuer symbol
DRTS
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:03:38 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sofer Uzi Chief Executive Officer, Director C/O ALPHA TAU MEDICAL LTD., JERUSALEM, ISRAEL /s/ Uzi Sofer 18 Mar 2026 0001968053

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DRTS Ordinary Shares 1,250,941 18 Mar 2026 Direct
holding DRTS Restricted Share Units 4,680 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DRTS Options 18 Mar 2026 Ordinary Shares 54,318 $1.10 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 54,318 $4.42 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 174,770 $11.50 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 8,945 $10.92 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 229,089 $10.92 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 10,657 $7.19 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 250,933 $7.19 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 46,905 $3.28 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 1,102,653 $3.57 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 43,257 $2.98 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 763,843 $3.48 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 24,460 $4.05 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 674,238 $3.07 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 15,527 $6.41 Direct F3
holding DRTS Options 18 Mar 2026 Ordinary Shares 396,680 $7.32 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
F2 These are options to acquire ordinary shares, which have fully vested as of the date hereof.
F3 These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
F4 These are options to acquire ordinary shares, which options which vest in quarterly equal installments for a period of four years commencing January 1, 2026, subject to the Reporting Person's continued service.